Clinical Research Directory
Browse clinical research sites, groups, and studies.
Communication Bridge 3 Study
Sponsor: University of Chicago
Summary
This study will use a randomized controlled trial design to evaluate the effect of two evidence-based treatments for adults with mild-moderate Primary Progressive Aphasia (PPA). The aim of the study is to help us better understand the effects of speech-language therapy on communication abilities in individuals with PPA.
Official title: Communication Bridge: Optimizing an Evidence-based Intervention for Individuals With Primary Progressive Aphasia
Key Details
Gender
All
Age Range
18 Years - 100 Years
Study Type
INTERVENTIONAL
Enrollment
200
Start Date
2024-08-23
Completion Date
2028-07-15
Last Updated
2025-05-30
Healthy Volunteers
No
Conditions
Interventions
Communication Bridge™
Evidence-based speech language therapy treatment will be compared and contrasted in the two arms of the study.
Evidence-Based Impairment Focused
Evidence-based speech language therapy treatment will be compared and contrasted in the two arms of the study.
Locations (1)
University of Chicago - American School Building
Chicago, Illinois, United States